Von Eschenbach Andrew C.

Von Eschenbach Andrew C. is listed in filings as Director at Bausch + Lomb Corporation. This profile follows SEC Form 4 activity through May 28, 2026, including purchase activity. Recent filings connect the profile to Bausch + Lomb Corporation (BLCO) and TriSalus Life Sciences, Inc. (TLSI). The current snapshot covers public activity from Aug 6, 2024 to May 28, 2026. Reported amounts are shown as $250.0K to $19.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.